Precision Medicines Development, Regulatory and Commercialisation

Our team has decades of large pharma and diagnostics experience working with the foremost companies globally. We provide strategic and operational support from drug-diagnostic co-development, regulatory through to launch readiness and market uptake of novel drugs and diagnostics.

Precision Medicines Development

  • Identification, due diligence and selection of diagnostic companies for partnering

  • Project management of companion diagnostics co-development programmes and diagnostic studies

  • Training, monitoring and trouble shooting to ensure consistent, high quality results for clinical diagnostics studies

  • Technical support for an array of diagnostic methods and technologies

  • Diagnostic assay development and implementation within clinical studies

  • Tech transfer to establish global diagnostic testing facilities

Precision Medicine Launch Readiness and Commercialisation

  • Developing and implementing Global Launch Plans

  • Co-ordinating and delivering diagnostic projects/initiatives at a global and local/in-country level

  • Development and implementation of diagnostic strategies to maximise testing for therapy choices

  • Diagnostics and lab network partner management

  • Diagnostic training of field force and capability development

  • Setting up and management of diagnostic studies

  • Managing quality assurance programmes

  • Diagnostic market research

  • Development and delivery of educational campaigns to drive diagnostic testing

  • Delivering diagnostic advisory boards

  • Support for health technology assessments

  • Accessing healthcare professional networks

Precision Medicine Regulatory Services

  • Regulatory and development advice for biomarkers, companion diagnostics, digital health and other devices across a range of therapy areas and regions

  • Developing global regulatory strategy for Precision Medicines

  • Regulatory landscape mapping, assessing regulatory risk, and developing global filing strategies

  • Ensuring global development plans meet global regulatory requirements

  • Supporting Regulatory Interactions/Submissions (e.g. FDA- SRD’s, IND’s, PMA’s, EMA – IVDR compliance, PMDA)

  • Advice on organisational development and outsourcing key regulatory activities​​​

Experience working with

GSK

Novartis

BMS

Astrazeneca

Roche

• GSK • Novartis • BMS • Astrazeneca • Roche